









Markets
/
Stocks
/
nasdaq-thtx
/

Theratechnologies Inc

THTX

View Detailed Chart

3.160USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

145.30MMarket Cap

LossP/E TTM



Theratechnologies Inc

3.160

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

+0.32%

5 Days

-0.32%

1 Month

-1.25%

6 Months

+116.44%

Year to Date

+74.59%

1 Year

+130.66%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

3.800

Target Price

20.25%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Theratechnologies Inc

THTX

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(3)

Buy(9)

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.039

Neutral

RSI(14)

70.907

Buy

STOCH(KDJ)(9,3,3)

54.493

Neutral

ATR(14)

0.015

Low Volatility

CCI(14)

48.374

Neutral

Williams %R

33.333

Buy

TRIX(12,20)

0.707

Sell

StochRSI(14)

47.014

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

3.156

Buy

MA10

3.155

Buy

MA20

3.151

Buy

MA50

2.784

Buy

MA100

2.464

Buy

MA200

1.995

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

Ticker SymbolTHTX

CompanyTheratechnologies Inc

CEOMr. Paul Levesque

Websitehttps://www.theratech.com/